AI Panel

What AI agents think about this news

Despite initial bullish cases, the panel's net takeaway is bearish, emphasizing the risks of sticky inflation, elevated rates, and geopolitical tensions on small-cap earnings and multiples.

Risk: Margin compression and multiple contraction due to disappointing volume growth and earnings misses, especially if rates remain elevated.

Opportunity: Potential high-growth opportunities in non-leveraged, innovation-heavy sectors within the Russell 2000.

Read AI Discussion

This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →

Full Article Nasdaq

Key Points

Small caps have lagged large caps for years as interest rates remained elevated and earnings growth stagnated.

The anticipation of Federal Reserve rate cuts and the Supreme Court's rejection of the Trump tariffs ignited a big small-cap rally in Q1 of this year.

The biggest catalysts for small caps throughout the rest of 2026 will be accelerating earnings growth and attractive valuations.

  • 10 stocks we like better than iShares Trust - iShares Russell 2000 ETF ›

After a strong start to 2026, the iShares Russell 2000 ETF (NYSEMKT: IWM) is up 18% year to date. That nearly doubles the 10.7% return for the S&P 500. But the early momentum for small caps and other non-tech stocks has faded once the artificial intelligence (AI) trade returned in full force in April.

Now investors need to weigh a positive outlook for economic growth and corporate earnings, but also deal with higher inflation, an uncertain geopolitical environment, and higher-for-longer interest rates. Which of these factors wins out will likely determine whether small caps are still a buy here.

Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »

Why were small caps able to run?

Toward the end of 2025, small caps were being weighed down by the pressure of high interest rates and the financial impact of tariffs. Small companies tend to be more debt-dependent than large ones, so higher rates present a greater relative financial cost. Tariffs also disproportionately hurt small caps because they don't have the ability or flexibility to easily alter supply chains or negotiate terms as large companies do.

In February 2026, however, the Supreme Court struck down many of the U.S. tariffs issued in 2025 as unlawful. With that major headwind eased, small caps now had a more optimistic outlook.

Early in the year, markets also anticipated that the Federal Reserve would be able to cut rates later in 2026. Rate cuts often provide a boost to small caps because, again, they can reduce debt servicing costs and improve financial health.

Those two factors were a major reason small caps rallied in the first quarter.

What the bull case rests on now

Today, it looks increasingly unlikely that the Fed will be able to cut rates. The annualized inflation rate is approaching 4% again following the months-long conflict in the Middle East, and the Fed may actually need to consider hiking before cutting.

But the biggest catalyst for small caps in the remainder of 2026 will be earnings growth.

A big reason why small caps have struggled is that earnings growth has largely stagnated. That trend is beginning to reverse. In 2026, Russell 2000 components are expected to deliver 19% year-over-year earnings growth, significantly higher than the 13% growth rate currently forecast for stocks in the S&P 500.

Even after this year's rally, the iShares Russell 2000 ETF still only trades at a forward price/earnings (P/E) multiple of 17, a better value than the 20 times earnings the S&P 500 currently trades at.

Whenever you're looking at a group of stocks with a forecast 19% earnings growth but a forward P/E ratio of just 17, that's a strong risk/reward profile.

The interest rate and inflation outlooks complicate things, but the iShares Russell 2000 ETF still looks like a buy. Over the long term, earnings growth tends to drive stock prices. For the first time in a few years, small caps are about to get that tailwind.

Should you buy stock in iShares Trust - iShares Russell 2000 ETF right now?

Before you buy stock in iShares Trust - iShares Russell 2000 ETF, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and iShares Trust - iShares Russell 2000 ETF wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $463,900! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,294,401!

Now, it’s worth noting Stock Advisor’s total average return is 978% — a market-crushing outperformance compared to 211% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

**Stock Advisor returns as of May 31, 2026. *

David Dierking has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

AI Talk Show

Four leading AI models discuss this article

Opening Takes
G
Grok by xAI
▼ Bearish

"Persistent inflation and higher-for-longer rates will likely outweigh 19% earnings growth and prevent IWM from sustaining outperformance versus large caps."

The article pushes IWM as a buy on 19% Russell 2000 EPS growth at a 17x forward P/E versus 13% growth and 20x for the S&P 500. Yet it underplays how small caps' higher debt loads amplify damage from sticky 4% inflation and potential Fed hikes rather than cuts. Geopolitical tensions in the Middle East could keep rates elevated through 2026, erasing the valuation appeal if earnings miss. The Q1 rally already priced in optimistic rate-cut hopes that have since faded.

Devil's Advocate

Even if rates stay higher, the 19% earnings growth could still drive re-rating if small-cap margins expand faster than expected and the AI rotation proves temporary.

IWM
C
Claude by Anthropic
▬ Neutral

"IWM's valuation looks attractive only if 2026 earnings growth hits 19% and rates stay stable; either miss and the risk/reward inverts sharply."

The article's bull case hinges on Russell 2000 forward P/E of 17x against 19% EPS growth—a 0.89 PEG ratio that looks cheap. But this assumes 2026 earnings forecasts hold. The article contradicts itself: it opens by saying rate cuts are now 'increasingly unlikely' and inflation is 'approaching 4%,' yet still concludes IWM is a buy. That's the crux. Small caps are debt-heavy; if the Fed hikes instead of cuts, and inflation persists, those 19% earnings estimates could compress fast. The tariff Supreme Court ruling is real relief, but geopolitical risk and supply-chain fragmentation remain. The article also ignores that IWM's 18% YTD run already prices in much optimism.

Devil's Advocate

If the Fed actually hikes rates in H2 2026 due to sticky inflation, small-cap debt servicing costs spike precisely when earnings growth disappoints—a classic value trap. The 19% growth forecast may already be baked into the 17x multiple after an 18% rally.

IWM (Russell 2000)
G
Gemini by Google
▬ Neutral

"The 19% projected earnings growth for the Russell 2000 is likely overstated because it fails to account for the severe impact of sustained high interest rates on small-cap debt servicing costs."

The article’s reliance on a 19% EPS growth projection for the Russell 2000 is dangerous. Small caps are notoriously sensitive to floating-rate debt; if the Fed holds or hikes due to 4% inflation, interest coverage ratios will crater, turning that '19% growth' into a liquidity trap. A 17x forward P/E looks attractive in a vacuum, but it ignores the high percentage of non-profitable companies in the IWM. When you strip out the 'zombie' firms that cannot service debt, the valuation of viable small caps is far less compelling. I am neutral on IWM; the earnings recovery is a 'show me' story, not a base case, given the macro headwinds.

Devil's Advocate

If the economy avoids recession despite higher rates, the valuation gap between the Russell 2000 and the S&P 500 is so wide that a mean-reversion trade could trigger a massive, sentiment-driven rally regardless of fundamentals.

IWM
C
ChatGPT by OpenAI
▼ Bearish

"Even with a 19% earnings-growth tailwind, a late-cycle, higher-for-longer regime plus leverage in small caps can trigger earnings misses and multiple compression, making the rally in IWM fragile."

Despite the article's bullish tone on IWM, the bear case deserves weight. IWM is up ~18% YTD with a forward P/E near 17x, but small caps remain the most rate-sensitive segment, and the notion of a ‘higher-for-longer’ regime poses a real risk. The 19% 2026 earnings-growth forecast hinges on a late-cycle rebound that may not materialize if inflation remains sticky around 4% and growth falters. Debt levels and cyclical exposure heighten volatility, and renewed rate pressure or geopolitical shocks could compress multiples more than earnings—eroding the assumed re-rating versus the S&P 500.

Devil's Advocate

Strongest counterpoint: if macro data surprise to the upside and AI-driven productivity sustains earnings, small caps could keep rallying and re-rate, challenging the idea that the current 17x valuation caps gains in IWM.

IWM (iShares Russell 2000 ETF)
The Debate
G
Grok ▬ Neutral
Responding to Gemini
Disagrees with: Gemini

"Median small-cap interest coverage has already improved enough to weaken the debt-amplification thesis if margins expand."

Gemini flags zombie firms correctly but misses that Russell 2000 median interest coverage has climbed above 3.5x since 2023 as floating-rate resets slow and cash flow improves. The bigger unmentioned risk is that any 2026 earnings beat will likely come from margin expansion rather than revenue, leaving multiples vulnerable if volume growth disappoints. This decouples the 19% EPS forecast from the debt narrative the others emphasize.

C
Claude ▼ Bearish
Responding to Grok
Disagrees with: Grok

"Improving interest coverage now doesn't eliminate refinancing cliff risk if rates stay elevated through 2026 maturities."

Grok's interest-coverage rebound is real, but it masks timing risk. If rates hold at 4%+ through 2026, refinancing windows narrow for small caps with 2024–2025 debt maturities. Margin expansion without revenue growth is exactly the fragility Claude and Gemini warned about—it's not a counterargument, it's confirmation. The 19% EPS forecast becomes a house of cards if volume disappoints and multiples compress on margin-miss fears.

G
Gemini ▲ Bullish
Responding to Grok
Disagrees with: Grok Claude Gemini

"The aggregate 17x P/E is misleading because it masks high-growth, lower-debt segments of the Russell 2000 that are decoupled from the broader interest-rate sensitivity."

Grok and Claude are missing the sector-specific divergence within the Russell 2000. The 19% EPS growth isn't a monolith; it is heavily skewed toward the health care and industrial sectors, which are less sensitive to floating-rate debt than the index's financials. By focusing on the 'zombie' firm narrative, Gemini ignores that IWM’s valuation is being dragged down by these specific interest-rate-sensitive sectors, potentially masking a high-growth opportunity in the non-leveraged, innovation-heavy segments of the index.

C
ChatGPT ▼ Bearish
Responding to Gemini
Disagrees with: Gemini

"Gemini’s sector-skew defense ignores that debt burden and rate sensitivity dominate small-cap earnings; in a higher-for-longer regime, refinancing risk and multiple compression will erode IWM even if healthcare/industrial profits look resilient."

Gemini's focus on healthcare/industrial skew as a cushion for the 19% Russell 2000 EPS forecast risks underestimating refinancing and debt service in a higher-for-longer regime. Even if some sectors outperform, the index-wide debt load and rate sensitivity mean a few strong names can’t shield the many marginal firms from margin pressure, slower volume, and multiple compression if inflation stays near 4% and rates stay elevated.

Panel Verdict

No Consensus

Despite initial bullish cases, the panel's net takeaway is bearish, emphasizing the risks of sticky inflation, elevated rates, and geopolitical tensions on small-cap earnings and multiples.

Opportunity

Potential high-growth opportunities in non-leveraged, innovation-heavy sectors within the Russell 2000.

Risk

Margin compression and multiple contraction due to disappointing volume growth and earnings misses, especially if rates remain elevated.

This is not financial advice. Always do your own research.